Matthew Lang - 15 Apr 2022 Form 4 Insider Report for Myovant Sciences Ltd.

Role
General Counsel & Corp. Secy.
Signature
/s/ Matthew Lang
Issuer symbol
N/A
Transactions as of
15 Apr 2022
Net transactions value
$0
Form type
4
Filing time
19 Apr 2022, 16:49:41 UTC
Previous filing
07 Apr 2022
Next filing
21 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MYOV Common Shares Award $0 +111,111 +64% $0.000000 284,039 15 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Common Shares are to be acquired upon the vesting of certain Restricted Stock Units ("RSUs") granted to the Reporting Person. 1/4 of the common shares underlying the RSUs vest on April 15, 2023, and 1/16 of the common shares underlying the RSUs vest each quarter thereafter, provided the Reporting Person has provided continuous service to the Issuer or its affiliates on each such date.